Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines

Abstract Background All-trans retinoic acid (ATRA) is currently being used to treat hematological malignancies, given the ability to inhibit cell proliferation. This effect seems to be related to epigenetic changes of the TERT (Telomerase Reverse Transcriptase) promoter. When hypomethylated, ATRA-in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lorena Losi, Angela Lauriola, Erica Tazzioli, Gaia Gozzi, Letizia Scurani, Domenico D’Arca, Jean Benhattar
Format: Artigo
Idioma:Inglês
Publicat: BMC 2019-07-01
Col·lecció:Journal of Ovarian Research
Matèries:
Ovarian cancer, serous ovarian carcinoma
ATRA
TERT
Telomerase
DNA methylation
Cell lines
Accés en línia:http://link.springer.com/article/10.1186/s13048-019-0536-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars